These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9127635)

  • 41. Melatonin as biological response modifier in cancer patients.
    Neri B; de Leonardis V; Gemelli MT; di Loro F; Mottola A; Ponchietti R; Raugei A; Cini G
    Anticancer Res; 1998; 18(2B):1329-32. PubMed ID: 9615811
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Biological, histological, and clinical impact of preoperative IL-2 administration in radically operable gastric cancer patients.
    Romano F; Cesana G; Berselli M; Gaia Piacentini M; Caprotti R; Bovo G; Uggeri F
    J Surg Oncol; 2004 Dec; 88(4):240-7. PubMed ID: 15565596
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunoendocrine therapy with low-dose subcutaneous interleukin-2 plus melatonin of locally advanced or metastatic endocrine tumors.
    Lissoni P; Barni S; Tancini G; Mainini E; Piglia F; Maestroni GJ; Lewinski A
    Oncology; 1995; 52(2):163-6. PubMed ID: 7854778
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A new neuroimmunotherapeutic strategy of subcutaneous low-dose interleukin-2 plus the long-acting opioid antagonist naltrexone in metastatic cancer patients progressing on interleukin-2 alone.
    Lissoni P; Malugani F; Bordin V; Conti A; Maestroni G; Tancini G
    Neuro Endocrinol Lett; 2002 Jun; 23(3):255-8. PubMed ID: 12080288
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Total pineal endocrine substitution therapy (TPEST) as a new neuroendocrine palliative treatment of untreatable metastatic solid tumor patients: a phase II study.
    Lissoni P; Malugani F; Brivio F; Piazza A; Vintimilla C; Giani L; Tancini G
    Neuro Endocrinol Lett; 2003; 24(3-4):259-62. PubMed ID: 14523367
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Do Th2 cells mediate the effects of glatiramer acetate in experimental autoimmune encephalomyelitis?
    Jee Y; Liu R; Bai XF; Campagnolo DI; Shi FD; Vollmer TL
    Int Immunol; 2006 Apr; 18(4):537-44. PubMed ID: 16481342
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Which immunological parameters are clinically essential to monitor IL-2 cancer immunotherapy?
    Lissoni P; Brivio F; Viviani S; Fumagalli L
    J Biol Regul Homeost Agents; 1999; 13(2):110-4. PubMed ID: 10503734
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The pineal gland as a central regulator of cytokine network.
    Lissoni P
    Neuro Endocrinol Lett; 1999; 20(6):343-349. PubMed ID: 11458197
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vaccination of dendritic cells loaded with interleukin-12-secreting cancer cells augments in vivo antitumor immunity: characteristics of syngeneic and allogeneic antigen-presenting cell cancer hybrid cells.
    Suzuki T; Fukuhara T; Tanaka M; Nakamura A; Akiyama K; Sakakibara T; Koinuma D; Kikuchi T; Tazawa R; Maemondo M; Hagiwara K; Saijo Y; Nukiwa T
    Clin Cancer Res; 2005 Jan; 11(1):58-66. PubMed ID: 15671528
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 22-ene-25-oxa-vitamin D: a new vitamin D analogue with profound immunosuppressive capacities.
    Daniel C; Schlauch T; Zügel U; Steinmeyer A; Radeke HH; Steinhilber D; Stein J
    Eur J Clin Invest; 2005 May; 35(5):343-9. PubMed ID: 15860047
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunotherapy with low-dose interleukin-2 in association with melatonin as salvage therapy for metastatic soft tissue sarcomas.
    Lissoni P; Barni S; Ardizzoia A; Tancini G
    Oncol Rep; 1997; 4(1):157-9. PubMed ID: 21590033
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Suppressive action of melatonin on the TH-2 immune response in rats infected with Trypanosoma cruzi.
    Santello FH; Frare EO; dos Santos CD; Caetano LC; Alonso Toldo MP; do Prado JC
    J Pineal Res; 2008 Oct; 45(3):291-6. PubMed ID: 18373553
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
    O'Malley BW; Li D; McQuone SJ; Ralston R
    Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Additive immunosuppressive effects of 1,25-dihydroxyvitamin D3 and corticosteroids on TH1, but not TH2, responses.
    Jirapongsananuruk O; Melamed I; Leung DY
    J Allergy Clin Immunol; 2000 Nov; 106(5):981-5. PubMed ID: 11080724
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Melatonin enhances IL-2, IL-6, and IFN-gamma production by human circulating CD4+ cells: a possible nuclear receptor-mediated mechanism involving T helper type 1 lymphocytes and monocytes.
    Garcia-Mauriño S; Gonzalez-Haba MG; Calvo JR; Rafii-El-Idrissi M; Sanchez-Margalet V; Goberna R; Guerrero JM
    J Immunol; 1997 Jul; 159(2):574-81. PubMed ID: 9218571
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Regulatory role of pro-Th1 and pro-Th2 cytokines in modulating the activity of Th1 and Th2 cells when B cell and macrophages are used as antigen presenting cells.
    Singh V; Agrewala JN
    BMC Immunol; 2006 Aug; 7():17. PubMed ID: 16889674
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phase-II randomized study of preoperative IL-2 administration in radically operable gastric cancer patients.
    Romano F; Piacentini MG; Franciosi C; Caprotti R; De Fina S; Cesana G; Uggeri F; Conti M; Uggeri F
    Hepatogastroenterology; 2004; 51(60):1872-6. PubMed ID: 15532847
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Biotherapy with the pineal immunomodulating hormone melatonin versus melatonin plus aloe vera in untreatable advanced solid neoplasms.
    Lissoni P; Giani L; Zerbini S; Trabattoni P; Rovelli F
    Nat Immun; 1998; 16(1):27-33. PubMed ID: 9789122
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Psychoneuroendocrine modulation of regulatory T lymphocyte system: in vivo and in vitro effects of the pineal immunomodulating hormone melatonin.
    Vigoré L; Messina G; Brivio F; Fumagalli L; Rovelli F; DI Fede G; Lissoni P
    In Vivo; 2010; 24(5):787-9. PubMed ID: 20952751
    [TBL] [Abstract][Full Text] [Related]  

  • 60. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol.
    Pinto RA; Arredondo SM; Bono MR; Gaggero AA; Díaz PV
    Pediatrics; 2006 May; 117(5):e878-86. PubMed ID: 16618789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.